<?xml version="1.0" encoding="utf-8"?>
<iati-activities xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" version="2.03" generated-datetime="2026-02-14T16:38:18.9729238+01:00" linked-data-default="http://data-service.theglobalfund.org/api">
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-TJK-C-UNDP-2</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Ending HIV and tuberculosis (“TB”) epidemics through evidence-based interventions and innovative approaches with a focus on key and vulnerable populations - Tajikistan (01-Jan-2024-31-Dec-2026)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Tajikistan, TB/HIV, United Nations Development Programme (UNDP Tajikistan)This program has the following goals: To support Tajikistan public health system by ensuring HIV prevention, timely detection, access to ART, addressing related human rights barriers, as well as providing quality HIV care and support with the focus on key and vulnerable populations..  To decrease the burden of tuberculosis and its impact over the general social and economic development in the country, by ensuring universal access to timely and quality diagnosis and treatment of all forms of TB, including latent TB, which will decrease illness and deaths and prevent further development of drug resistance.. The objectives of this program are: To ensure effective HIV response measures among most at risk populations, - including prevention, early HIV diagnostics and immediate treatment initiation, - to reach 95-95-95 HIV care  targets.  To reach the pre-pandemic level of access to early and quality DR-TB diagnostics and treatment and scale up integrated people-centered model of TB care.  To dramatically scale up efforts on TB/DR-TB prevention,  including universal access to TB preventive treatment.  To ensure integrated care for people affected both by TB and HIV disease.  To strengthen national public heath response to ensure universal, people-centered, efficient, human rights and gender-responsive approach to HIV, TB and integrated TB/HIV services</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<other-identifier ref="TJK-C-UNDPP02" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="2" />
		<activity-date type="1" iso-date="2024-01-01" />
		<activity-date type="2" iso-date="2024-01-01" />
		<activity-date type="3" iso-date="2026-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Olga, AVDEEVA</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>olga.avdeeva@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="TJ" percentage="100">
			<narrative xml:lang="en">Tajikistan</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="45">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="23">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="4">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="28">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for key population (KP) programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programing for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people in prisons and other closed settings -&gt; Harm reduction interventions for drug use for prisoners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Condom and lubricant programing for PUD</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="7">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Needle and syringe programs for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Opioid substitution therapy and other medically assisted drug dependence treatment for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Condom and lubricant programing for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programing for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Eliminating stigma and discrimination in all settings</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="14">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="7">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="23">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; Integration/coordination across disease programs and at the service delivery level</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Quality management systems and accreditation</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="13">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="10">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Preventive treatment</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Key populations</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2026-01-01" />
			<period-end iso-date="2026-12-31" />
			<value currency="USD" value-date="2024-01-01">9395214.06</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2025-01-01" />
			<period-end iso-date="2025-12-31" />
			<value currency="USD" value-date="2024-01-01">8442683.53</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2024-01-01" />
			<period-end iso-date="2024-12-31" />
			<value currency="USD" value-date="2024-01-01">5518945.54</value>
		</budget>
		<transaction ref="49464bdd-e467-4b4a-93f9-d2446255dee5">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-12-13" />
			<value currency="USD" value-date="2023-12-13">10977476.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to TJK-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="faad4d2a-4cec-49ac-9cee-ce35f6d254ca">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-05-28" />
			<value currency="USD" value-date="2025-05-28">3700263.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to TJK-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8077da51-d245-48a2-8b29-2d9a8572eeec">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-05-28" />
			<value currency="USD" value-date="2025-05-28">-519217.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to TJK-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="95c835a8-ab15-4222-af57-e7db1962fe00">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-11-25" />
			<value currency="USD" value-date="2025-11-25">2348803.53</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to TJK-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2d379fe9-21d9-462a-b5a5-bdc67ceef312">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-01-16" />
			<value currency="USD" value-date="2025-01-16">3468500.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="bcd8b61e-c006-415b-a89b-604e3bb5e02c">
			<transaction-type code="3" />
			<transaction-date iso-date="2026-01-13" />
			<value currency="USD" value-date="2026-01-13">2348803.53</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b9e8a1a3-d92f-4330-9068-50efc1a46c52">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-11-12" />
			<value currency="USD" value-date="2024-11-12">500000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e4bbd5c9-fd09-4ec9-9459-f762b8f77fab">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-06-03" />
			<value currency="USD" value-date="2025-06-03">3700263.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="578973df-0de6-43e5-80af-8b8495e80626">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-01-04" />
			<value currency="USD" value-date="2024-01-04">6489759.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/TJK-C-UNDP" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-TJK-C-UNDP-1</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Strengthening Supportive Environment and Scaling up Prevention, Treatment and Care to reduce the burden of HIV and TB in the Republic of Tajikistan - Tajikistan (01-Jan-2021-31-Dec-2023)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Tajikistan, TB/HIV, United Nations Development Programme (UNDP Tajikistan)This program has the following goals: To reduce the burden of HIV and TB in Tajikistan. The objectives of this program are: To ensure effective HIV response measures among most at risk populations, - including prevention, early HIV diagnostics and immediate treatment initiation, - to reach 90-90-90 HIV care targets.  To scale up access for early and quality TB, DR-TB and LTBI diagnosis, treatment and care.  To ensure integrated care for people affected both by TB and HIV disease.  To strengthen national public heath response to ensure universal, patient-centered, efficient, human rights and gender sensitive approach to HIV, TB and integrated TB/HIV services</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<other-identifier ref="TJK-C-UNDPP01" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="4" />
		<activity-date type="1" iso-date="2021-01-01" />
		<activity-date type="2" iso-date="2021-01-01" />
		<activity-date type="3" iso-date="2023-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Olga, AVDEEVA</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>olga.avdeeva@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="TJ" percentage="100">
			<narrative xml:lang="en">Tajikistan</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="30">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="40">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="3">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="27">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="7">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Behavior change interventions</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Condom and lubricant programing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Needle and syringe programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Opioid substitution therapy and other medically assisted drug dependence treatment</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="16">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery and HIV care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="10">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Case management, clinical operations and therapeutics</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Country-level coordination and planning</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="8">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID diagnostics and testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 CSS: Social mobilization</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Gender-based violence prevention and post violence care (COVID-19)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Infection prevention and control, and protection of the health workforce</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Laboratory systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Mitigation for HIV programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Mitigation for TB programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Risk communication</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Surveillance: Epidemiological investigation and contact tracing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="16">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Procurement capacity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Community health workers: Education and production</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Education and production of new health workers (excluding community health workers)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="17">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="9">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2023-01-01" />
			<period-end iso-date="2023-12-31" />
			<value currency="USD" value-date="2021-01-01">13494169.75</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2021-01-01" />
			<period-end iso-date="2021-12-31" />
			<value currency="USD" value-date="2021-01-01">3259597.37</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2022-01-01" />
			<period-end iso-date="2022-12-31" />
			<value currency="USD" value-date="2021-01-01">13805241.49</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2024-01-01" />
			<period-end iso-date="2024-12-31" />
			<value currency="USD" value-date="2021-01-01">3080399.19</value>
		</budget>
		<transaction ref="1f452171-146c-4f77-af55-842713c4b9fb">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-06-27" />
			<value currency="USD" value-date="2025-06-27">-519217.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="70b7e33e-ed31-4f96-98da-12672ec86cfe">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-06-09" />
			<value currency="USD" value-date="2023-06-09">5596313.34</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2eefb6cb-7e2c-48a7-ae19-cfc6a77eba9a">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-07-23" />
			<value currency="USD" value-date="2023-07-23">100000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="69893e6f-45bc-45ab-9a9f-503611f3b92e">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-02-25" />
			<value currency="USD" value-date="2022-02-25">100000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="709ab0a5-d471-4999-a8e6-254702f2968d">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-10-04" />
			<value currency="USD" value-date="2021-10-04">-8097950.20</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d4ffaab2-2d1b-4834-8965-2eb43ecf25bc">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-01-05" />
			<value currency="USD" value-date="2021-01-05">16843513.01</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="3510d26b-a83c-4982-82a8-a333159888cd">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-06-09" />
			<value currency="USD" value-date="2023-06-09">-1321487.38</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1598af9e-a902-45a5-9740-7fbdf293773a">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-10-04" />
			<value currency="USD" value-date="2021-10-04">13766048.20</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="554bd6e1-1753-45b9-aac2-5220a71a2ab4">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-09-21" />
			<value currency="USD" value-date="2022-09-21">10711572.38</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="543059f2-8074-401a-b16c-f8d95d5d7e9b">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-11-03" />
			<value currency="USD" value-date="2022-11-03">-50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="feee8e65-541b-4809-b65f-79266ee3c9aa">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-02-25" />
			<value currency="USD" value-date="2022-02-25">-50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b177fcc2-9154-4cde-91d1-b96419b2b60a">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-07-07" />
			<value currency="USD" value-date="2021-07-07">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="659d428a-7b25-42ef-a8cc-594197291cb9">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-09-21" />
			<value currency="USD" value-date="2022-09-21">-5974363.20</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="40581cc3-75c9-4169-ae66-eaf8881d9d71">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-09-30" />
			<value currency="USD" value-date="2024-09-30">-39690.23</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a311c999-ed6d-47d0-9d50-50e1c2839f2c">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-04-04" />
			<value currency="USD" value-date="2023-04-04">95643.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="bd1ac3f3-6fb9-480e-8ed8-e933566d5183">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-11-16" />
			<value currency="USD" value-date="2023-11-16">468608.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b1c8f4d0-586e-4234-a840-fe0a6491fd93">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-09-29" />
			<value currency="USD" value-date="2022-09-29">3201090.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="50fae04b-f1ad-4e17-a90c-d9969c65a4c3">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-11-24" />
			<value currency="USD" value-date="2022-11-24">108185.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f4064734-7293-4ca8-ae1d-d87cfaa6a819">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-11-24" />
			<value currency="USD" value-date="2022-11-24">680127.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b837aa42-ec4f-42f6-84b9-e453eeddf6b6">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-04-11" />
			<value currency="USD" value-date="2024-04-11">100000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e6714662-39f3-4e48-8534-4d5402ba7e84">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-04-04" />
			<value currency="USD" value-date="2023-04-04">5068029.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="4ca60d53-2468-4513-9203-eb7aac21223b">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-09-29" />
			<value currency="USD" value-date="2022-09-29">237011.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="bc306dc5-db92-4375-9ab2-b22f123da281">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-08-03" />
			<value currency="USD" value-date="2023-08-03">2619067.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="42061d3a-0fd0-4874-ac57-92241cf99fd7">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-01-20" />
			<value currency="USD" value-date="2022-01-20">197114.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="68a1d0a7-bc54-40f3-81b3-ab83fe859106">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-12-21" />
			<value currency="USD" value-date="2023-12-21">500000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="3a5b7ae6-6272-4ec2-a0f3-1ac22a72df26">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-07-11" />
			<value currency="USD" value-date="2023-07-11">1310393.34</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8b8d6673-b60e-4198-85df-8780b60c7681">
			<transaction-type code="7" />
			<transaction-date iso-date="2024-10-01" />
			<value currency="USD" value-date="2024-10-01">-39690.23</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="bd3d50d4-159d-463b-8a68-26b8c75fd3d2">
			<transaction-type code="7" />
			<transaction-date iso-date="2025-06-30" />
			<value currency="USD" value-date="2025-06-30">-519217.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c7c5626d-bb57-4ecc-8573-8c441d30350c">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-10-07" />
			<value currency="USD" value-date="2021-10-07">1054452.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="98626a2c-2902-4dc6-9572-d5ef7acfb322">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-01-20" />
			<value currency="USD" value-date="2022-01-20">2257140.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="21fba453-58d8-4630-bfc2-c9d459f72e4e">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-11-18" />
			<value currency="USD" value-date="2021-11-18">4282979.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8b4cc20f-cb9f-4c35-960e-795304138c61">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-03-14" />
			<value currency="USD" value-date="2022-03-14">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e074757f-b238-4494-acfc-1d32bceaa191">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-01-08" />
			<value currency="USD" value-date="2021-01-08">8745562.81</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to TJK-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Tajikistan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/TJK-C-UNDP" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for TJK-C-UNDPP01</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="6000" />
					<actual value="4288" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="6100" />
					<actual value="4158" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="5900" />
					<actual value="4444" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="1050" />
					<actual value="613" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="1140" />
					<actual value="413" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="1200" />
					<actual value="467" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="67.90" />
					<actual value="68.70" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="61.69" />
					<actual value="57.20" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="74.60" />
					<actual value="67.10" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="74.64" />
					<actual value="67.10" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="67.86" />
					<actual value="68.70" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="61.70" />
					<actual value="57.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="96.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="96.00" />
					<actual value="94.30" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="96.00" />
					<actual value="100.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="80.80" />
					<actual value="74.80" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="66.50" />
					<actual value="62.40" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="66.46" />
					<actual value="62.40" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="80.75" />
					<actual value="74.80" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="73.60" />
					<actual value="68.10" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="73.61" />
					<actual value="68.10" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="72.70" />
					<actual value="66.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="70.60" />
					<actual value="59.70" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="77.40" />
					<actual value="58.80" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="72.72" />
					<actual value="66.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="56.70" />
					<actual value="52.50" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="52.96" />
					<actual value="57.50" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="53.00" />
					<actual value="57.50" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="60.60" />
					<actual value="53.00" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="56.67" />
					<actual value="52.50" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="60.64" />
					<actual value="53.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="70.14" />
					<actual value="62.30" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="70.10" />
					<actual value="62.30" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="75.20" />
					<actual value="56.30" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="80.00" />
					<actual value="59.50" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="45.34" />
					<actual value="38.80" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="45.30" />
					<actual value="38.80" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="42.37" />
					<actual value="32.80" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="48.51" />
					<actual value="43.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="42.40" />
					<actual value="32.80" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="48.50" />
					<actual value="43.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of people in prisons and other closed settings reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="6552" />
					<actual value="8861" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="6880" />
					<actual value="12535" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="7088" />
					<actual value="12769" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="1050" />
					<actual value="502" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="1200" />
					<actual value="442" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="1140" />
					<actual value="482" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="5504" />
					<actual value="10400" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="5670" />
					<actual value="7800" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="5242" />
					<actual value="6235" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="54.30" />
					<actual value="48.90" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="49.40" />
					<actual value="40.40" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="59.70" />
					<actual value="54.10" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="49.35" />
					<actual value="40.40" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="54.28" />
					<actual value="48.90" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="59.72" />
					<actual value="54.10" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="61.90" />
					<actual value="50.80" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="56.49" />
					<actual value="50.30" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="58.20" />
					<actual value="55.10" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="58.18" />
					<actual value="55.10" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="56.50" />
					<actual value="50.30" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="61.92" />
					<actual value="50.80" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for TJK-C-UNDPP01</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="68.00" />
					<actual value="71.50" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="75.00" />
					<actual value="78.21" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="70.00" />
					<actual value="78.21" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="75.00" />
					<actual value="83.01" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="70.00" />
					<actual value="83.01" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="82.43" />
					<actual value="54.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="85.14" />
					<actual value="54.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="83.33" />
					<actual value="54.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="83.33" />
					<actual value="55.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="82.43" />
					<actual value="55.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="85.14" />
					<actual value="55.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV not on ART at the end of the reporting period among people living with HIV who were either on ART at the end of the last reporting period or newly initiated on ART during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="9.50" />
					<actual value="4.07" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="9.00" />
					<actual value="4.87" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="8.50" />
					<actual value="4.87" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="8.50" />
					<actual value="5.01" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="9.00" />
					<actual value="5.01" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs reporting using sterile injecting equipment the last time they injected</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="80.00" />
					<actual value="90.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men reporting using a condom the last time they had anal sex with a male partner</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="85.00" />
					<actual value="78.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reporting using a condom with their most recent client</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="85.00" />
					<actual value="82.20" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for TJK-C-UNDPP01</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB patients with RR-TB and/or MDR-TB</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="19.00" />
					<actual value="21.60" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="19.00" />
					<actual value="12.76" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="18.00" />
					<actual value="8.61" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of AIDS-related deaths per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="1.8" />
					<actual value="0.7" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="1.6" />
					<actual value="0.49" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="1.4" />
					<actual value="0.62" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="2.1" />
					<actual value="1.6" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="2" />
					<actual value="1" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="1.9" />
					<actual value="1" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men who are living with HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="2.00" />
					<actual value="4.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers who are living with HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="2.50" />
					<actual value="2.90" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs who are living with HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="11.50" />
					<actual value="8.90" />
				</period>
			</indicator>
		</result>
	</iati-activity>
</iati-activities>